Effects of ketoprofen, morphine, and kappa opioids on pain-related depression of nesting in mice

Pain

Volumn 156, Issue 6, 2015, Pages 1153-1160

  Negus, S Stevens ^a   Neddenriep, Bradley ^a   Altarifi, Ahmad A ^a,b   Carroll, F Ivy ^c   Leitl, Michael D ^a   Miller, Laurence L ^a,d  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^c RTI INTERNATIONAL   (United States)

^d AUGUSTA UNIVERSITY   (United States)

Author keywords

JDTic; Kappa opioid; Ketoprofen; Mice; Morphine; Nesting; Pain depressed behavior; U69,593

Indexed keywords

FREUND ADJUVANT; KAPPA OPIATE RECEPTOR ANTAGONIST; KETOPROFEN; LACTIC ACID; MORPHINE; 7-HYDROXY-N-(1-((4-(3-HYDROXYPHENYL)-3,4-DIMETHYL-1-PIPERIDINYL)METHYL)-2-METHYLPROPYL)-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXAMIDE; BENZENEACETAMIDE DERIVATIVE; KAPPA OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PIPERIDINE DERIVATIVE; PYRROLIDINE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; INFLAMMATORY PAIN; MALE; MOUSE; MOUSE MODEL; NESTING; NONHUMAN; PRIORITY JOURNAL; AGONISTS; ANALYSIS OF VARIANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; COMPLICATION; DOSE RESPONSE; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PAIN; PHYSIOLOGY;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZENEACETAMIDES; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FREUND'S ADJUVANT; KETOPROFEN; MALE; MICE; MICE, INBRED ICR; MORPHINE; NESTING BEHAVIOR; PAIN; PIPERIDINES; PYRROLIDINES; RECEPTORS, OPIOID, KAPPA; TETRAHYDROISOQUINOLINES;

EID: 84943631129     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000171     Document Type: Article

References (46)

1. Andrews N, Legg E, Lisak D, Issop Y, Richardson D, Harper S, Pheby T, Huang W, Burgess G, Machin I, Rice AS. Spontaneous burrowing behaviour in the rat is reduced by peripheral nerve injury or inflammation associated pain. Eur J Pain 2012;16:485-95.
2. Broadbear JH, Negus SS, Butelman ER, de Costa BR, Woods JH. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay. Psychopharmacology (Berl) 1994;115:311-19.
3. Butler RK, Finn DP. Stress-induced analgesia. Prog Neurobiol 2009;88: 184-202.
4. Cahill CM, Taylor AM, Cook C, Ong E, Moron JA, Evans CJ. Does the kappa opioid receptor system contribute to pain aversion? Front Pharmacol 2014;5:253.
5. Carroll FI, Carlezon WA Jr. Development of kappa opioid receptor antagonists. J Med Chem 2013;56:2178-95.
6. Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, Harris LS. Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Eur J Pharmacol 2004;501: 111-19.
7. Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 1994;23:129-38.
8. Cobos EJ, Ghasemlou N, Araldi D, Segal D, Duong K, Woolf CJ. Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia. PAIN 2012;153:876-84.
9. Cobos EJ, Portillo-Salido E. "Bedside-to-bench" behavioral outcomes in animal models of pain: beyond the evaluation of reflexes. Curr Neuropharmacol 2013;11:560-91.
10. Deacon RM. Assessing nest building in mice. Nat Protoc 2006;1: 1117-19.
11. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. PAIN 2005;113:9-19.
12. Elmer GI, Pieper JO, Negus SS, Woods JH. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. PAIN 1998;75:129-40.
13. Ferguson DR, Bailey MM. Reproductive performance of mice in disposable and standard individually ventilated cages. J Am Assoc Lab Anim Sci 2013;52:228-32.
14. Gaskill BN, Karas AZ, Garner JP, Pritchett-Corning KR. Nest building as an indicator of health and welfare in laboratory mice. J Vis Exp 2013;82: 51012.
15. Grace PM, Strand KA, Maier SF, Watkins LR. Suppression of voluntary wheel running in rats is dependent on the site of inflammation: evidence for voluntary running as ameasure of hind paw-evoked pain. J Pain 2014; 15:121-8.
16. Jirkof P. Burrowing and nest building behavior as indicators of well-being in mice. J Neurosci Methods 2014;234:139-46.
17. Jirkof P, Cesarovic N, Rettich A, Nicholls F, Seifert B, Arras M. Burrowing behavior as an indicator of post-laparotomy pain in mice. Front Behav Neurosci 2010;4:165.
18. Kwilasz AJ, Negus SS. Dissociable effects of the cannabinoid receptor agonists delta 9-tetrahydrocannabinol and cp55940 on pain-stimulated versus pain-depressed behavior in rats. J Pharmacol Exp Ther 2012;343: 389-400.
19. Latham N, Mason G. From house mouse to mouse house: the behavioral biology of free-living mus musculus and its implications in the laboratory. App Anim Behav Sci 2004;86:261-89.
20. Lee CT. Genetic analyses of nest-building behavior in laboratory mice (Mus musculus). Behav Genet 1973;3:247-56.
21. LeitlMD, Onvani S, BowersMS, Cheng K, Rice KC, CarlezonWAJr, Banks ML, Negus SS. Pain-related depression of the mesolimbic dopamine systemin rats: expression, blockade by analgesics, and role of endogenous kappa-opioids. Neuropsychopharmacology 2014;39:614-24.
22. Leitl MD, Potter DN, Cheng K, Rice KC, Carlezon WA Jr, Negus SS. Sustained pain-related depression of behavior: effects of intraplantar formalin and complete freund's adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers in rats. Mol Pain 2014;10:62.
23. Martin LJ, Hathaway G, Isbester K, Mirali S, Acland EL, Niederstrasser N, Slepian PM, Trost Z, Bartz JA, Sapolsky RM, Sternberg WF, Levitin DJ, Mogil JS. Reducing social stress elicits emotional contagion of pain in mouse and human strangers. Curr Biol 2015;25:326-32.
24. Martin TJ, Buechler NL, Kahn W, Crews JC, Eisenach JC. Effects of laparotomy on spontaneous exploratory activity and conditioned operant responding in the rat: a model for postoperative pain. Anesthesiology 2004;101:191-203.
25. Matson DJ, Broom DC, Carson SR, Baldassari J, Kehne J, Cortright DN. Inflammation-induced reduction of spontaneous activity by adjuvant: a novel model to study the effect of analgesics in rats. J Pharmacol Exp Ther 2007;320:194-201.
26. Melzack R, Katz J. Pain assessment in adult patients. In: McMahon LR, Koltzenburg M, editors. Textbook of pain. London: Elsevier, 2006. pp. 291-304.
27. Miller LL, Picker MJ, Schmidt KT, Dykstra LA. Effects of morphine on pain-elicited and pain-suppressed behavior in CB1 knockout and wildtype mice. Psychopharmacology (Berl) 2012;215:455-65.
28. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain HS, Belknap JK, Hubert L, Elmer GI, Chung JM, Devor M. Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. PAIN 1999;80:67-82.
29. National-Research-Council. Guide for the care and use of laboratory animals, eighth edition. Washington DC: National Academy Press, 2011.
30. Negus SS. Expression and treatment of pain-related behavioral depression. Lab Anim (NY) 2013;42:292-300.
31. Negus SS, Bilsky EJ, Pereira Do Carmo G, Stevenson GW. Rationale and methods for assessment of pain-depressed behavior in preclinical assays of pain and analgesia. In: Szallasi A, editor. Methods inmolecular biology: analgesia. New York: Humana Press, 2010. pp. 79-91.
32. Negus SS, Morrissey EM, Rosenberg M, Cheng K, Rice KC. Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats. Psychopharmacology (Berl) 2010;210:149-59.
33. Negus SS, Vanderah TW, Brandt MR, Bilsky EJ, Becerra L, Borsook D. Preclinical assessment of candidate analgesic drugs: recent advances and future challenges. J Pharmacol Exp Ther 2006;319:507-14.
34. Pande AC, Pyke RE, Greiner M, Cooper SA, Benjamin R, Pierce MW. Analgesic efficacy of the kappa-receptor agonist, enadoline, in dental surgery pain. Clin Neuropharmacol 1996;19:92-7.
35. Pande AC, Pyke RE, Greiner M, Wideman GL, Benjamin R, Pierce MW. Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain. Clin Neuropharmacol 1996;19:451-6.
36. Percie du Sert N, Rice AS. Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain. Br J Pharmacol 2014;171: 2951-63.
37. Rock ML, Karas AZ, Rodriguez KB, Gallo MS, Pritchett-Corning K, Karas RH, Aronovitz M, Gaskill BN. The time-to-integrate-to-nest test as an indicator of wellbeing in laboratory mice. J Am Assoc Lab Anim Sci 2014; 53:24-8.
38. Rutten K, Schiene K, Robens A, Leipelt A, Pasqualon T, Read SJ, Christoph T. Burrowing as a non-reflex behavioural readout for analgesic action in a rat model of sub-chronic knee joint inflammation. Eur J Pain 2014;18:204-12.
39. Schepers RJ, Mahoney JL, Gehrke BJ, Shippenberg TS. Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation. PAIN 2008;138:423-39.
40. Seguin L, Le Marouille-Girardon S, Millan MJ. Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparison to other classes of antinociceptive agent. PAIN 1995;61: 325-43.
41. Sorge RE, Martin LJ, Isbester KA, Sotocinal SG, Rosen S, Tuttle AH, Wieskopf JS, Acland EL, Dokova A, Kadoura B, Leger P, Mapplebeck JC, McPhail M, Delaney A, Wigerblad G, Schumann AP, Quinn T, Frasnelli J, Svensson CI, Sternberg WF, Mogil JS. Olfactory exposure to males, including men, causes stress and related analgesia in rodents. Nat Methods 2014;11:629-32.
42. Stevens SS. On the theory of scales of measurement. Science 1946;103: 677-80.
43. Stevenson GW, Bilsky EJ, Negus SS. Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. J Pain 2006;7:408-16.
44. Stevenson GW, Cormier J, Mercer H, Adams C, Dunbar C, Negus SS, Bilsky EJ. Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. Life Sci 2009;85:309-15.
45. Wadenberg ML. A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist. CNS Drug Rev 2003;9:187-98.
46. WhitesideGT,Pomonis JD, Kennedy JD. An industry perspective on the role and utility of animal models of pain in drug discovery. Neurosci Lett 2013; 557 PtA:65-72.